Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease

Highlights • Treatment of APP/PS1 mice with antiTLR2 antibody for 7 months improves spatial learning. • Aβ plaque burden is reduced in antiTLR2 antibody-treated APP/PS1 mice. • These changes are associated with decreased microglial activation as indicated by reduced immunoreactivity for CD68. • Anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain, behavior, and immunity behavior, and immunity, 2016-11, Vol.58, p.191-200
Hauptverfasser: McDonald, Claire L, Hennessy, Edel, Araiz, Ana Rubio, Keogh, Brian, McCormack, William, McGuirk, Peter, Reilly, Mary, Lynch, Marina A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Treatment of APP/PS1 mice with antiTLR2 antibody for 7 months improves spatial learning. • Aβ plaque burden is reduced in antiTLR2 antibody-treated APP/PS1 mice. • These changes are associated with decreased microglial activation as indicated by reduced immunoreactivity for CD68. • Anti-TLR2 antibody treatment reduced GFAP immunoreactivity in hippocampus of APP/PS1 mice.
ISSN:0889-1591
1090-2139
DOI:10.1016/j.bbi.2016.07.143